AKBA

AKBA

USD

Akebia Therapeutics Inc. Common Stock

$2.125+0.025 (1.190%)

实时价格

Healthcare
Drug Manufacturers - Specialty & Generic
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$2.100

最高价

$2.145

最低价

$2.070

成交量

4.47M

公司基本面

市值

563.4M

所属行业

Drug Manufacturers - Specialty & Generic

国家/地区

United States

交易统计

平均成交量

4.04M

交易所

NCM

货币

USD

52周价格范围

最低价 $1.52当前价 $2.125最高价 $4.079

相关新闻

GlobeNewswire

Akebia Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced

查看更多
Akebia Therapeutics to Present at Upcoming Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Akebia Therapeutics, Lowers Price Target to $6

HC Wainwright & Co. analyst Matthew Caufield maintains Akebia Therapeutics with a Buy and lowers the price target from $8 to $6.

查看更多
HC Wainwright & Co. Maintains Buy on Akebia Therapeutics, Lowers Price Target to $6
Analyst Upgrades

BTIG Maintains Buy on Akebia Therapeutics, Lowers Price Target to $5

BTIG analyst Julian Harrison maintains Akebia Therapeutics with a Buy and lowers the price target from $10 to $5.

查看更多
BTIG Maintains Buy on Akebia Therapeutics, Lowers Price Target to $5
GlobeNewswire

Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients

CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced

查看更多
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients